ARTICLE | Company News
Manhattan deal
February 7, 2011 8:00 AM UTC
Manhattan said former Ariston Pharmaceuticals Inc. shareholders will receive 8.8 million shares of Manhattan stock after the biotech said it would continue development of AST-915 to treat essential t...